Range Low Price High Price Comment
30 days $0.86 $1.30 Tuesday, 30th Apr 2024 BLUE stock ended at $0.89. This is 3.93% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 8.88% from a day low at $0.86 to a day high of $0.94.
90 days $0.86 $1.92
52 weeks $0.86 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Feb 01, 2016 $41.37 $46.41 $40.29 $45.75 1 693 400
Jan 29, 2016 $39.66 $42.46 $39.10 $41.36 1 113 900
Jan 28, 2016 $42.22 $43.33 $39.23 $39.66 985 300
Jan 27, 2016 $45.23 $46.13 $41.86 $42.53 1 116 200
Jan 26, 2016 $44.45 $45.98 $41.90 $45.24 1 214 100
Jan 25, 2016 $44.55 $46.49 $43.86 $44.14 768 000
Jan 22, 2016 $44.09 $46.20 $42.52 $45.03 1 593 500
Jan 21, 2016 $43.84 $47.00 $42.04 $42.96 1 265 600
Jan 20, 2016 $40.45 $45.49 $37.40 $44.22 1 798 800
Jan 19, 2016 $45.34 $45.99 $40.48 $41.84 1 365 600
Jan 15, 2016 $44.50 $46.33 $42.57 $44.64 1 246 900
Jan 14, 2016 $46.65 $48.59 $42.16 $46.57 1 675 100
Jan 13, 2016 $50.38 $51.88 $45.78 $46.17 1 399 200
Jan 12, 2016 $45.95 $51.89 $45.86 $49.81 2 216 600
Jan 11, 2016 $55.49 $56.00 $43.51 $44.64 3 347 800
Jan 08, 2016 $55.05 $58.69 $54.87 $55.44 995 400
Jan 07, 2016 $57.33 $57.48 $53.31 $54.10 1 196 800
Jan 06, 2016 $61.41 $61.59 $57.16 $58.23 971 700
Jan 05, 2016 $63.54 $65.00 $61.67 $61.76 847 200
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT